Advancing -targeted therapy in thyroid cancer: insights and implications from the LIBRETTO-001 study.
0/5 보강
APA
Baek HS, Lim DJ (2025). Advancing -targeted therapy in thyroid cancer: insights and implications from the LIBRETTO-001 study.. Translational cancer research, 14(8), 4486-4490. https://doi.org/10.21037/tcr-2025-370
MLA
Baek HS, et al.. "Advancing -targeted therapy in thyroid cancer: insights and implications from the LIBRETTO-001 study.." Translational cancer research, vol. 14, no. 8, 2025, pp. 4486-4490.
PMID
40950664 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (3)
- Cost-Utility Analysis of Early Detection with Ultrasonography of Differentiated Thyroid Cancer: A Retrospective Study on a Korean Population.
- Initial Experiences of Selective RET Inhibitor Selpercatinib in Adults with Metastatic Differentiated Thyroid Carcinoma and Medullary Thyroid Carcinoma: Real-World Case Series in Korea.
- Cost-Effectiveness of Active Surveillance Compared to Early Surgery of Small Papillary Thyroid Cancer: A Retrospective Study on a Korean Population.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Impact of Rituximab Maintenance on outcomes in Follicular Lymphoma: An indian experience.
- Adverse events associated with the use of nivolumab in the middle-aged and older population (>45 years): A pharmacovigilance analysis based on the FAERS database.
- Rare cases in two Chinese MEN2A families with RET C634Y germline mutation-a homozygous female patient and heterozygous identical twins: a systematic review of literature.
- Coping with checkpoint inhibitor adverse events: Assisting cancer patients in skills development - insights from the Immuno'Act© pre-experimental pilot study.
- Immune-Related Adverse Events in Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors: Insights From a FAERS Disproportionality Analysis.
- Outcomes and toxicities of immune checkpoint inhibitors in patients with lung cancer and pre-existing autoimmune disease.